A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance

• Main Authors: King T.H., Kemmler C.B., Guo Z., Mann D., Lu Y., Coeshott C., Gehring A.J., Bertoletti A., Ho Z.Z., Delaney W., Gaggar A., Subramanian G.M., McHutchison J.G., Shrivastava S., Lee Y.-J.L., Kottilil S., Bellgrau D., Rodell T., Apelian D.
• 其他作者: DUKE-NUS MEDICAL SCHOOL
• 格式: Article
• 出版: Public Library of Science 2018
• 在線閱讀: http://scholarbank.nus.edu.sg/handle/10635/142461
• 機構: National University of Singapore

10.1371/journal.pone.0101904